OP6 Innovation Ltd is a family investment office, specialising in helping early stage and high growth SME’s. Based near Cambridge, OP6 supports ambitious technology and manufacturing companies in a number of ways.
Alongside other funding providers and where beneficial we invest in minority equity stakes. Our investments are made in accordance with our conscious capital principles.
Working with existing owners and managers, we provide practical advice and knowledge to support the development of highly effective top teams to meet the challenging targets of the business.
We drive business growth through international sales expansion and the successful introduction of new products. In addition we take an active role in the implementation of a congruent M&A strategy.
OP6 Innovation Ltd was established in 2017 by the Mckernan Family.
Ian Mckernan enjoyed a successful career in a number of mid- size manufacturing companies. Holding various CEO and Group Chairman positions, Ian drove growth and innovation within family and private equity backed businesses.
With extensive experience of international growth, companies led by Ian have been recognised with a Queens Award and featured in the Sunday Times Fast Track listings.
Building on Ian’s experience, the Mckernan family established OP6 Innovation with a clear purpose to support the growth of early stage and ambitious SME’s.
OP6 is a specific crystal lattice structure, called orthorhombic.
READ MOREOP6 Innovation takes it name from a specific crystal structure, OP6, an orthorhombic crystalline lattice.
In the early 1970’s the family’s first business, MP United Drug Company, processed high purity grades of Calcium Chloride. The purest grade was the crystalline hexahydrate form CaCl2.6H2O - an OP6 lattice structure.
The unique manufacturing process used worthless scrap or contaminated raw material. After processing by dissolving, filtering, cooling and separating in a centrifuge, high value colourless crystals were produced and sold into a number of high end pharmaceutical applications.
The application of knowledge, investment and leadership to produce a significant increase in value AND improve the world around us typifies the approach of OP6 Innovation.
Our investment in early stage companies and SME’s are guided by the following:
The companies' activities must be socially responsible and contribute to the improvement of the planet’s environment.
Our investments are focused on growth, thereby accelerating positive change.
There is no pre-determined term or exit outcome for the investment - we stay with you for the journey.
OP6 Innovation Ltd and its Directors have supported or are invested in the following companies:
Invested 2016, Exited 2021
Molecular Products Group is an international manufacturer of specialist purification devices, Critical technology providing breathable environments in medical, security and industrial applications.
Invested 2018
High temperature treatment of medical waste. Small scale units having optimised technology for destroying high level clinical waste in situ. Major advantages are the reduction of expensive ‘waste miles’, transporting medical waste to central incinerators as well as reducing contamination risk factors.
Invested 2019
Danish based company developing technology that converts methane into concentrated proteins which can be used to feed animals. A substitute for increasingly scarce fishmeal, giving reduced CO2 emissions, and allowing more land to be allocated for food production.
Invested 2019
CPH2 is applying new technologies to deliver hydrogen based solution for transportation, power and gas sectors. Their low emissions and storage technologies offer reduced emissions and clean power storage.
Invested 2019
Owner of rural outdoor leadership centre, which hosts a number or social and personal development activities. Main centre for Giles Hutchins and his cutting-edge leadership in nature activities.
Invested 2020
Based in the beautiful West Country, Sage Tech have developed disruptive technology to capture, recover and re-use volatile anaesthetic gases. In addition to recovering very expensive materials, the use of Sage Tech’s patented approach prevents the release of environmentally harmful HCF containing gases.
Invested 2021
Aqdot is a spin out from Cambridge University. Their transformational chemical technology is exceptional at capturing, holding and releasing key materials and molecules. Applications include odour control, gas purification and gene delivery.
Invested 2021
Intelligent Air Disinfection. Clinical air monitoring and cleansing producing dramatic reductions in cross contamination within Hospitals.
Invested 2022
Fast, accurate healthcare testing. Providing at-home healthcare testing with immediate results and at low cost.
Invested 2022
Early stage company, improving drug development by reducing common and expensive safety failures. Interdisciplinary approach using drug discovery and toxicology expertise supported by AI.
Invested 2023
Information on buildings can be difficult to locate and hard to keep hold of. Building Passport store organise and share building information to comply with new legislation, save money and enhance safety.
Invested 2023
Aim to produce affordable, carbon negative Hydrogen gas from biogenic feedstocks. Their radical process enables production of Clear Hydrogen from sustainable materials in a cost competitive and scaleable manner.
Complete the form below and we will get back to you, or call us on 07802 843 773 to speak to a human! Alternatively, you can send us an email: contact@op6innovation.com
The information you submit via this contact form will only be used to deal with your enquiry. For further information on how we use and store your data, please see our Data Privacy Policy.
